Over the past 15 years, Mr. Wehrly has led growth-stage medical technology companies including Premia Spine, Vivex Biologics, Synaptive Medical, and PQ Bypass through regulatory approval, commercialization, strategic alliances, and acquisition. Earlier in his career, he held senior executive roles at Medtronic and Covidien, managing large global business units. He currently serves as Board Advisor to Premier Spine.
His combined experience in scaling innovative technologies and leading complex global organizations will support Medasense as it expands adoption of its AI-driven NOL – Nociception Level Index monitoring technology.
